INIS
patients
100%
anticoagulants
81%
thrombin
52%
plasma
51%
risks
46%
comparative evaluations
39%
concentration
39%
drugs
36%
laboratories
36%
assessments
32%
reviews
32%
proteins
31%
data
29%
evaluation
27%
levels
27%
testing
25%
heparin
25%
diseases
23%
antibodies
22%
doses
22%
control
22%
inhibition
21%
values
20%
performance
19%
administration
19%
sensitivity
19%
applications
19%
monitoring
19%
thrombosis
18%
tyrosine
18%
nanoparticles
18%
kinases
18%
covid-19
17%
in vitro
17%
screening
16%
vaccines
15%
cancer
15%
humans
15%
information
15%
rats
15%
blood
15%
reagents
15%
safety
14%
validation
14%
biological markers
14%
women
13%
in vivo
13%
synthesis
13%
molecular weight
13%
receptors
12%
vitamin k
12%
inflammation
12%
therapy
12%
myeloid leukemia
11%
detection
11%
neutrophils
11%
toxicity
11%
estrogens
11%
production
11%
coronaviruses
11%
design
10%
surgery
10%
interactions
9%
emergencies
9%
mass spectrometry
9%
range
9%
tissues
9%
venoms
8%
endothelium
8%
recommendations
8%
accuracy
8%
standardization
8%
hemostatics
7%
molecules
7%
populations
7%
adhesion
7%
lungs
7%
management
7%
reduction
6%
medicines
6%
peaks
6%
dimers
6%
wave forms
6%
prothrombin
6%
kidneys
6%
capacity
6%
thromboplastin
6%
hormones
6%
substrates
6%
ligands
6%
hemolysis
5%
metabolism
5%
symptoms
5%
liquids
5%
stability
5%
aggregation
5%
lipids
5%
nucleosomes
5%
migration
5%
mortality
5%
Keyphrases
Direct Oral Anticoagulants
5%